Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly. 

1. STOCK NEWS:

• JPMorgan (JPM) reported upbeat Q3 adjusted earnings [more]
• Delta (DAL) also reported better than expected Q3 adjusted earnings [more]
• Hasbro (HAS) announced the passing of CEO Brian Goldner [more]
• Qualcomm (QCOM) announced a new $10B stock repurchase authorization [more]
• BlackRock (BLK) reported better than expected Q3 results [more]

2. WALL STREET CALLS:

• Morgan Stanley upgrades Plug Power (PLUG) with $40 target into investor day [more]
• Wayfair (W) downgraded to Hold from Buy at Jefferies [more]
• Monster Beverage (MNST) downgraded to Hold from Buy at Jefferies [more]
• Baird downgrades Skyworks (SWKS) on "secular slowdown" in RF content [more]
• Oppenheimer starts "emerging leader" Jasper Therapeutics (JSPR) with Outperform rating, $21 price target [more]

3. AROUND THE WEB:

• Apple (AAPL) is set to cut iPhone production targets due to chip shortage, Bloomberg says [more]
• Electronic Arts (EA) talks with FIFA about renewing game rights "hit the wall," NY Times says [more]
• Short-seller Scorpion remains short on Berkeley Lights (BLI) after Q3 pre-announcement [more]
• The NHTSA is seeking answers from Tesla (TSLA) over the lack of a recall when it updated Autopilot software, AP reports [more]
• Amazon (AMZN) is shopping for used long-range Boeing (BA) and Airbus (EADSY) cargo planes, Bloomberg says [more]

4. MOVERS:

• Revance (RVNC) rises after announcing it continues to expect the FDA's approval of the company’s Biologics License Application for DaxibotulinumtoxinA for Injection [more]
• Vimeo (VMEO) up after reporting its monthly year-over-year growth through September [more]
• Vistra (VST) higher after announcing a new $2B share buyback [more]
• GrowGeneration (GRWG) declines after cutting its fiscal year 2021 guidance and after announcing the termination of the HGS Hydro acquisition [more]
• Crispr Therapeutics (CRSP) falls after announcing updated results from the company's ongoing Phase 1 CARBON trial evaluating the safety and efficacy of CTX110, its wholly-owned allogeneic CAR-T cell therapy [more]

5. EARNINGS/GUIDANCE:

• SGH (SGH) reported upbeat Q4 results [more]
• Wipro (WIT) reported better than expected Q2 revenue [more]
• Zynex (ZYXI) reiterated its Q3 revenue guidance [more]
• Inuvo (INUV) reported upbeat Q3 revenue [more]
• Stoneridge (SRI) provided lower than expected Q3 adjusted earnings guidance [more]

INDEXES:

The Dow fell 0.53, or 0.0015%, to 34,377.81, the Nasdaq gained 105.71, or 0.73%, to 14,571.64, and the S&P 500 advanced 13.15, or 0.30%, to 4,363.80.